States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors
GM Prizes Awarded To Gleevec Pioneers Druker, Lydon, And To Peto, Sulston, Waterston
Clinical Trial System Inefficient, UPCI Director Tells Senate
Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading
NCCS Changes Web Domain; NCCN Plans Clinical Trials Network
Funding Opportunities.
Trending Stories
- Lou Weiner: Poetry and art help us imagine my mother’s world as a hidden child of the Holocaust
- ACOG says it will no longer accept federal funding
- Knight Cancer Institute receives record-setting $2B gift from the Knights—and self-governance within OHSU
Brian Druker returns to executive role as president of the new Knight Cancer Group - When public service ends abruptly, do books provide solace? An escape? Perspective?
Former NIH and FDA employees tell us what they are reading in 2025 - Andrea Werblin Reid’s unflinching poetry documents the realities of cancer care, clinical trials, and loss
Her collection, “To See Yourself As You Vanish,” will be published three years after her death - The Directors: Mary Beckerle and Neli Ulrich on delivering cancer care across five states
Honoring the Jon Huntsman Sr. political perspective: “I’m not a member of any party except the Cancer Party”
